Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02048488
Title A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Belizatinib

Age Groups: adult
Covered Countries USA | ESP

Additional content available in CKB BOOST